| Title: |
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED) : an international, randomised, open-label, blinded-endpoint, phase 3 trial |
| Authors: |
Anderson, Craig S.; Huang, Yining; Lindley, Richard I.; Chen, Xiaoying; Arima, Hisatomi; Chen, Guofang; Li, Qiang; Billot, Laurent; Delcourt, Candice; Bath, Philip M.; Broderick, Joseph P.; Demchuk, Andrew M.; Donnan, Geoffrey A.; Durham, Alice C.; Lavados, Pablo M.; Lee, Tsong-Hai; Levi, Christopher (R19066); Martins, Sheila O.; Olavarria, Veronica V.; Pandian, Jeyaraj D.; Parsons, Mark W.; Pontes-Neto, Octavio M.; Ricci, Stefano; Sato, Shoichiro; Sharma, Vijay K.; Silva, Federico; Song, Lili; Thang, Nguyen H.; Wardlaw, Joanna M.; Wang, Ji-Guang; Wang, Xia; Woodward, Mark; Chalmers, John; Robinson, Thompson G.; Krause, M.; Priglinger, M.; Day, S.; Jala, S.; Carcel, C.; Malavera, A.; Ray, E.; Wijeratne, T.; Celestino, S.; Law, L. Y.; Ng, G.; Nagao, K.; Weiss, G.; Titton, N.; Batista, C.; Zan, D. |
| Publisher Information: |
U.K., Lancet Publishing Group |
| Publication Year: |
2019 |
| Collection: |
University of Western Sydney (UWS): Research Direct |
| Subject Terms: |
XXXXXX - Unknown |
| Description: |
Background: Systolic blood pressure of more than 185 mm Hg is a contraindication to thrombolytic treatment with intravenous alteplase in patients with acute ischaemic stroke, but the target systolic blood pressure for optimal outcome is uncertain. We assessed intensive blood pressure lowering compared with guideline-recommended blood pressure lowering in patients treated with alteplase for acute ischaemic stroke. Methods: We did an international, partial-factorial, open-label, blinded-endpoint trial of thrombolysis-eligible patients (age ≥18 years) with acute ischaemic stroke and systolic blood pressure 150 mm Hg or more, who were screened at 110 sites in 15 countries. Eligible patients were randomly assigned (1:1, by means of a central, web-based program) within 6 h of stroke onset to receive intensive (target systolic blood pressure 130–140 mm Hg within 1 h) or guideline (target systolic blood pressure |
| Document Type: |
article in journal/newspaper |
| File Description: |
print |
| Language: |
English |
| Relation: |
The Lancet--0140-6736--1474-547X Vol. 393 Issue. 10174 pp: 877-888 |
| DOI: |
10.1016/S0140-6736(19)30038-8 |
| Availability: |
https://doi.org/10.1016/S0140-6736(19)30038-8; http://hdl.handle.net/1959.7/uws:66999 |
| Accession Number: |
edsbas.679CC875 |
| Database: |
BASE |